Lifeboat Foundation

The longest — and last — full moon of the year will appear on Monday night and peak on Tuesday.

December’s full moon, also known as the Cold Moon and Long Night Moon, will reach peak illumination at 7:33 p.m. ET on Tuesday, according to NASA. It will look like a full moon until Thursday morning. The Old Farmer’s Almanac details specific moonrise times for different ZIP codes across the United States.

To view the full moon, it’s not rocket science: NASA recommends going outside and looking up at the sky. Using a telescope or binoculars will magnify the moon and clarify details on its surface.

A recent study published in the journal Physical Review D marks a significant advancement in cosmology. A team of researchers has analyzed over one million galaxies to delve into the origins of the universe’s current cosmic structures.

This study contributes to the understanding of the ΛCDM model, the standard framework for the universe, which posits the significance of cold dark matter (CDM) and dark energy (the cosmological constant, Λ).

The model theorizes that primordial fluctuations, originating at the universe’s inception, acted as catalysts for the formation of all celestial objects, including stars, galaxies, and galaxy clusters.

This was suggested by Gustave Fechner and other philosophers.

How about planets? Can they have minds? This idea, that planets are also conscious beings, seems to be at the heart of a new theory put forth by astrobiologists. The premise of this thought experiment is that bacteria and plants working together have altered planets like Earth, giving them a new lease on life.

This research, published in the International Journal of Astrobiology, provides a scale by which planets’ intelligence can be evaluated. It’s shocking to consider an extraterrestrial organism intelligent rather than a sentient animal like a human. But in a way, a planet can have a “green mind”; this paradigm suggests novel approaches to coping with climate change, technological upheaval, and other emergencies.

Continue reading “Earth Itself May Be an Intelligent Being, Suggests New Theory” »

The Limiting Factor joins Rebellionaire to talk about the latest wild news about the Tesla Megapacks. Rebellionaires check out www.Rebellionaire.com Rebellionaire is a brand of Halter Ferguson Financial. www.hffinancial.com/disclaimer

That Sports Illustrated debacle is only the start of a massive artificial intelligence disruption of the journalism industry.

Synchron’s electrodes are delivered via blood vessel.

Until now, only about 50 humans have ever had BCIs implanted in their brains.

A tool made by grad students is the ultimate “geoguesser,” using its knowledge of Google Street View to track down any photo’s location.

A new ISO standard aims to provide an overarching framework for the responsible development of AI.

The International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC) have approved a new international standard, ISO/IEC 42001. This standard is designed to help organizations develop and use AI systems responsibly.

ISO/IEC 42,001 is the world’s first standard for AI management systems and is intended to provide useful guidance in a rapidly evolving technology area. It addresses various challenges posed by AI, such as ethical considerations, transparency and continuous learning. For organizations, the standard is intended to provide a structured way to balance the risks and opportunities associated with AI.

The CHOOSE system, an innovative approach combining brain organoids and genetics, transforms autism research by allowing detailed analysis of mutations and their effects on brain development.

Does the human brain have an Achilles heel that ultimately leads to Autism? With a revolutionizing novel system that combines brain organoid technology and intricate genetics, researchers can now comprehensively test the effect of multiple mutations in parallel and at a single-cell level within human brain organoids.

This technology, developed by researchers from the Knoblich group at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences and the Treutlein group at ETH Zurich, permits the identification of vulnerable cell types and gene regulatory networks that underlie autism spectrum disorders. This innovative method offers unparalleled insight into one of the most complex disorders that challenge the human brain with implications that bring autism clinical research much-needed hope.